Buy GLOW Peptide Blend in Australia
Buy GLOW in Australia from Macropus Peptides as a single 70mg research vial that combines three compounds: BPC-157, TB-500 and the copper peptide GHK-Cu. Each acts through a different route in laboratory models, BPC-157 through growth factor and nitric oxide signalling, TB-500 through actin binding and GHK-Cu through copper transport, so the blend lets a lab examine all three together from one reconstitution and one lot number. The powder is freeze-dried as one cake in a sealed vial, labelled with the blend name, total strength, batch code and storage temperature, and the certificate for each lot reports every component separately. GLOW is priced and ready to order, costs well under the three matching single vials, and each component is still sold alone for control work. Add bacteriostatic water and we send the parcel from Australia to any Australian address. For in-vitro laboratory research by adults only, never for human or animal use.
| Compound | GLOW BPC + TB + GHK-Cu |
|---|---|
| Amount | 70 mg |
| Form | Lyophilised powder |
| Category | Recovery research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
GLOW BPC + TB + GHK-Cu 70mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy GLOW Peptide Australia: 70mg Blend Vial
Macropus Peptides supplies GLOW as one priced 70mg vial holding three research compounds dried together: BPC-157, TB-500 and GHK-Cu. It is the three-part blend in our recovery range, ready to order from Australian stock, and a single vial gives one mixing step and one batch record across all three peptides.
GLOW peptide Australia: what the blend is
The name spells out the contents. BPC-157 is a pentadecapeptide drawn from a protective gastric protein. TB-500 is synthetic material modelled on thymosin beta 4, the actin-binding protein. GHK-Cu is the tripeptide glycine, histidine and lysine holding a copper ion. Blends of this type are normally made with GHK-Cu as the largest share, 50mg, beside 10mg apiece of the other two, but the certificate for your lot records what was actually measured in that batch, and those numbers should drive every calculation. Combining them leaves each molecule unchanged. Counted in molecules rather than milligrams, the copper peptide dominates even more: 50mg of GHK-Cu is roughly 125 micromoles, against about 7 micromoles of BPC-157 and 2 of thymosin beta 4, because the three chains run to 3, 15 and 43 residues.
GLOW blend: how each component works in research
For BPC-157, tendon fibroblast studies point to outgrowth and migration driven through focal adhesion kinase, with vessel studies pointing to the VEGFR2 receptor. The thymosin beta 4 component grips free actin monomers and parks them outside filaments, which governs shape change and cell crawling. GHK grips copper very tightly and can pass it to cells in a controlled form, and its copper complex has been examined for its influence on collagen output by fibroblasts. None of these mechanisms has been published for the three-part mixture itself.
GLOW research: what the published studies show
The evidence behind the blend is the evidence for its parts. The copper tripeptide entered the literature through a 1973 Nature New Biology report on a plasma factor tested on cultured liver cells, and fifteen years later FEBS Letters carried fibroblast work measuring collagen made in its presence. For BPC-157, the key 2011 paper in the Journal of Applied Physiology used tendon fibroblasts, while Trends in Molecular Medicine surveyed the thymosin beta 4 literature in 2005. No study has examined the blend as a product, which is why single-compound controls matter. Our three-peptide blend research studies library holds the papers.
GLOW 70mg vial specifications
| Specification | Detail |
|---|---|
| Compound | GLOW BPC + TB + GHK-Cu |
| Amount | 70 mg |
| Form | Lyophilised powder |
| Category | Recovery research |
| Storage | -20 °C, protect from light |
The three peptides share one freeze-dried cake, faintly blue from the copper complex. Printed on the label: blend name, total strength, batch code, freezer temperature. Request the certificate with that batch code, and each component appears on its own line.
GLOW price in Australia against three single vials
| Strength | Price | Price per mg |
|---|---|---|
| GLOW BPC + TB + GHK-Cu 70mg | $199.99 | $2.86 per mg |
The 70mg blend carries a listed Australian dollar price and ships from stock. The fairest test is the three matching singles: a 10mg BPC-157 vial, a 10mg TB-500 vial and a 50mg GHK-Cu vial together cost roughly two thirds more than one GLOW vial, and they need three reconstitutions instead of one. The GLOW bundle and the starter kit add supplies to the same vial for a small step up in price.
GLOW 70mg: where to buy in Australia
Seventy milligrams is the one fill offered for this blend, aimed at laboratories running a combined arm across a longer series. Made up with 7 mL of diluent, the blend holds 10 mg per mL of total peptide, and 3.5 mL doubles that to 20 mg per mL. Whatever the volume, the copper peptide stays at five times the concentration of either partner on the customary split, so any working dilution keeps that ratio.
GLOW vs single vials: compare before you buy
Each component is studied through a separate mechanism, so together they cover three different corners of repair biology. BPC-157 work centres on growth factor receptor signalling and blood flow, thymosin beta 4 work on how cells move, and GHK-Cu work on copper delivery and the proteins cells lay down around themselves. Laboratories that already study two or three of these compounds often want them in a fixed ratio, prepared once and drawn from one batch, rather than weighing and mixing three vials. The blend gives exactly that, at the price of giving up control over the ratio.
Buying the parts separately gives full control. BPC-157, TB-500 and GHK-Cu are each listed on their own, and a 10mg, a 10mg and a 50mg vial between them make up the same 70mg. Separate vials suit designs that need one component as a control or a different ratio. The blend suits designs where the three-way mixture is the thing being studied. Leave out the copper peptide and the pair becomes the BPC-157 and TB-500 blend, a useful comparison arm when isolating what GHK-Cu adds.
Best place to buy GLOW peptide Australia
- Sold online at macropuspeptides.com, priced at $199.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
GLOW how to get: order the blend online
- Add the 70mg GLOW vial to the cart
- Add single vials for control arms
- Include diluent for reconstitution
- Confirm adult research use and pay
- Keep the batch code handy
GLOW calculator: bac water for the 70mg blend
The calculator reports total peptide per mL for whatever volume you enter. As a guide, 7 mL yields 10 mg per mL and 3.5 mL yields 20 mg per mL. Ten millilitres gives the tidiest component sums: total peptide sits at 7 mg per mL, a 50mg GHK-Cu share at 5 mg per mL and each 10mg share at 1 mg per mL; rely on the certificate amounts for exact figures. The starter kit pairs the vial with a 3 mL bottle, giving roughly 23.3 mg per mL of total peptide.
Is GLOW available in Australia
As a research material, yes. Not one of the three components is entered in the ARTG or holds TGA approval, so the blend is off limits for use in people or animals. Every component also carries its own Poisons Standard position, and a lab should check all three before ordering.
GLOW for sale Australia wide
The blend travels from local Australian stock to capital cities and country towns alike, including Canberra, Darwin and Townsville. For a four-part version with KPV added, see KLOW. The GLOW bundle sits alongside it, with the individual compounds in our recovery research range.
References
- Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology. 1973.
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988.
- Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005.
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.